Novartis’ Cosentyx gets Japanese approval for psoriasis, psoriatic arthritis
First interleukin-17A inhibitor to get Japanese nod for either indication
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Torrent Pharma in agreement with Reliance Life Sciences
Reliance Life Sciences will manufacture these products at its facility in Navi Mumbai and supply to Torrent Pharma for a period of…
1st draft of national IPR policy released
The Department of Industrial Policy and Promotion (DIPP) has published the first draft of the national IPR policy yesterday. Dated…
Dr Reddy’s, IPCA Labs products come under Canada govt scanner
Health Canada, the North American country’s food and drug regulator, has asked Canadian importers to quarantine health products…
Med devices gets 100% FDI
Industry hails move; asks for more changes to "pro imports" policies
CCI approves multi-billion dollar deal between GlaxoSmithKline and Novartis
It involves acquisition of GSK's portfolio of oncology products by Novartis for $16 billion
National conference on ‘Drug Discovery and Drug Targeting in Metabolic Diseases’…
Around 120 participants took part in the event
Clinical research in 2015: The ghost of Christmas past, present and yet to come
Clinical research in India has gone through Dickensian times in the past two years. Alishan Naqvee, Partner and Abhijeet Das,…
Cipla bags Rs 1,100 cr order for HIV drugs from South Africa
The medication will be produced at the company's 23,000 square meter manufacturing site in Kwazulu-Natal
Panacea Biotec in pact with international pharma co
Panacea Biotec shall receive an upfront research fee, as well as milestone payments linked with the development of the product